Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?.
Hanquet, G; Perrocheau, A; Kissling, E; Bruhl, DL; Tarragó, D; STUART, J; Stefanoff, P; Heuberger, S; Kriz, P; Vergison, A; De Greeff, SC; Amato-Gauci, A; Celentano, LP; ECDC Country Experts for Pneumococcal Disease,;
2010
Vaccine, (2010).28 23 10.1016/j.vaccine.2010.03.069.
Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization.
Licciardi, PV; Balloch, A; Russell, FM; MULHOLLAND, EK; Tang, ML K;
2010
Vaccine, (2010).28 22 10.1016/j.vaccine.2010.03.033.
Confidence in vaccines in developing countries: social, cultural, economic and political influences.
MULHOLLAND, K; Korczak, V; Tangcharoensathien, V;
2010
Journal of epidemiology and community health, (2010).64 7 10.1136/jech.2008.085712.
Randomized trials to study the nonspecific effects of vaccines in children in low-income countries.
Shann, F; Nohynek, H; SCOTT, JA; Hesseling, A; Flanagan, KL; Working Group on Nonspecific Effects of Vaccines,;
2010
The Pediatric infectious disease journal, (2010).29 5 10.1097/INF.0b013e3181c91361.
Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study).
O'Brien, SJ; Rait, G; Hunter, PR; Gray, JJ; Bolton, FJ; Tompkins, DS; McLauchlin, J; Letley, LH; Adak, GK; Cowden, JM; Evans, MR; Neal, KR; Smith, GE; Smyth, B; TAM, CC; RODRIGUES, LC;
2010
BMC medical research methodology, (2010).10 1 10.1186/1471-2288-10-39.
Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva.
Clements, MF; Gidwani, K; Kumar, R; Hostomska, J; Dinesh, DS; Kumar, V; Das, P; Müller, I; Hamilton, G; Volfova, V; Boelaert, M; Das, M; Rijal, S; Picado, A; Volf, P; Sundar, S; Davies, CR; ROGERS, ME;
2010
The American journal of tropical medicine and hygiene, (2010).82 5 10.4269/ajtmh.2010.09-0336.
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.
Russell, FM; Carapetis, JR; Balloch, A; Licciardi, PV; Jenney, AW J; Tikoduadua, L; Waqatakirewa, L; Pryor, J; Nelson, J; Byrnes, GB; Cheung, YB; Tang, ML K; MULHOLLAND, EK;
2010
Vaccine, (2010).28 19 10.1016/j.vaccine.2010.02.087.
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.
Russell, FM; Licciardi, PV; Balloch, A; Biaukula, V; Tikoduadua, L; Carapetis, JR; Nelson, J; Jenney, AW J; Waqatakirewa, L; Colquhoun, S; Cheung, YB; Tang, ML K; MULHOLLAND, EK;
2010
Vaccine, (2010).28 18 10.1016/j.vaccine.2010.02.065.
Asymptomatic rotavirus infections in England: prevalence, characteristics, and risk factors.
Phillips, G; Lopman, B; RODRIGUES, LC; TAM, CC;
2010
American journal of epidemiology, (2010).171 9 10.1093/aje/kwq050.
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.
Melegaro, A; Choi, YH; George, R; EDMUNDS, WJ; MILLER, E; Gay, NJ;
2010
BMC infectious diseases, (2010).10 1 10.1186/1471-2334-10-90.